对5-氨基水杨酸不耐受的溃疡性结肠炎患者结肠切除风险增加
该回顾性研究纳入2014-2018年日本东京及周边三家医院的1788例溃疡性结肠炎患者,按对5-氨基水杨酸(5-ASA)耐受与否分组,采用Cox比例风险模型分析显示,不耐受组结肠切除风险显著高于耐受组(HR 4.92,95%CI 2.58-9.38)。
要点
- 5-ASA不耐受的UC患者结肠切除率为11.5%,耐受组为2.6%。
- 校正混杂因素后,不耐受组结肠切除风险是耐受组的4.92倍(95%CI 2.58-9.38)。
- 因不耐受停用5-ASA的患者结肠切除风险更高。
核心结论
- 因不耐受而停用5-ASA的溃疡性结肠炎患者,其结肠切除风险高于对第一、第二或第三种5-ASA化合物耐受的患者。
研究设计与样本
- 回顾性研究,从日本东京及周边三家医院2014-2018年的病历中获取溃疡性结肠炎患者数据,共纳入1788例患者。
- 患者分为对任何5-ASA化合物耐受组(1684例)和对一种或多种5-ASA化合物不耐受导致停用组(104例)。
主要发现
- 耐受组43例(2.6%)行结肠切除术,不耐受组12例(11.5%)行结肠切除术。
- 校正性别、年龄、吸烟和结肠炎范围后,不耐受组结肠切除风险高于耐受组(HR 4.92;95%CI 2.58-9.38)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although 5-aminosalicylate (5-ASA) is the therapy of first choice in ulcerative colitis (UC), some patients cannot tolerate it because of side effects. Previous reports have not investigated whether 5-ASA intolerance is associated with the risk of colectomy. AIM: To investigate the associations between 5-ASA tolerance and colectomy among UC patients METHODS: The data of UC patients who visited any of three hospitals during 2014-2018 in and around Tokyo, Japan, were retrospectively obtained from the medical records. Patients were categorized as (a) tolerant to any 5-ASA compounds ("tolerant to 5-ASA") and (b) patients who were intolerant to one or more 5-ASA compounds leading to refrainment from their further use ("intolerant to 5-ASA"). The association between 5-ASA tolerance and colectomy was examined by Cox proportional hazards model adjusted for sex, age, smoking and extent of colitis. RESULTS: Of 1788 patients, 1684 were "tolerant to 5-ASA" while 104 were "intolerant to 5-ASA". Colectomy was performed in 43 (2.6%) of the patients tolerant to 5-ASA and 12 (11.5%) of the patients intolerant to 5-ASA. After adjusting for all covariates, the risk of undergoing colectomy was higher in the "intolerant to 5-ASA" group than in the "tolerant to 5-ASA" group (hazard ratio: 4.92; 95% confidence interval: 2.58-9.38). CONCLUSION: Patients in whom 5-ASA was discontinued due to intolerance had a higher risk of undergoing colectomy than patients tolerant to their first, second or third 5-ASA compounds.
引用
- Hibiya S, Matsuyama Y, Fujii T, et al. 5-aminosalicylate-intolerant patients are at increased risk of colectomy for ulcerative colitis. Aliment Pharmacol Ther. 2020. PMID: 33159485. doi:10.1111/apt.16120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。